In Western countries, sex differences in renal cell carcinoma (RCC) histology and survival have been previously described: compared with men, clear cell subtype is more common but overall prognosis is better among women. The goal of the present study was to examine sex differences in RCC histology and survival in Japan, using a large-scale population-based data set.
| INTRODUCTION
Renal cell carcinoma (RCC) ranks as the sixth most common type of cancer in men and 10th among women, worldwide, accounting for 5% and 3% of overall cancer incidence, respectively. 1 The incidence rate for RCC in Asian countries, including Japan, is roughly one-third compared with that in Western countries, 1 and the lower RCC incidence in Japan may be attributable to the lower prevalence of obesity (a prominent risk for RCC 2 ) in that country compared with the Western settings. However, the incidence has been rising in recent years in Japan. [1] [2] [3] Advanced imaging modalities, together with changes in lifestyle and behavioral risks (such as smoking, obesity, hypertension, and occupational stress), may underlie the increase in incidence. [3] [4] [5] Prognostic differences according to histological subtypes are well described. In the United States (USA), studies using the Surveillance, Epidemiology, and End Results (SEER) database suggest that the most common histological subtype is the clear cell subtype (approximately 80%-90%), followed by the papillary (approximately 4%-13%) and chromophobe (approximately 2%-5%) subtypes. [6] [7] [8] Compared with the clear cell subtype, patients with papillary and chromophobe subtypes tend to have better prognosis (hazard ratio [HR] approximately 0.67-0.98), but patients with other rare histological subtypes (eg, collecting duct and sarcomatoid differentiation) tend to have a poorer prognosis (HR approximately 1.81-2.21). 8 Previous single-center studies in the United States are consistent with this pattern. 9, 10 More recently, studies in Western settings have reported sex differences in RCC histology and survival. [11] [12] [13] [14] The clear cell subtype is likely more prevalent among women compared with men (88% vs 85%). 11 In addition, among all incident RCC, the papillary subtype tends to be approximately 0.5 to 0.6 times less prevalent, but the chromophobe subtype tends to be approximately 1.6 to 2.3 times more prevalent among women compared with men. 12, 13 Sex differences in RCC histology, particularly in the clear cell subtype, may be partly attributed to lifestyle and behavioral factors such as obesity, 15 which is generally more prevalent in women than men across most countries, 16 and smoking. 17 However, compared with men, RCC prognosis has been reported to be better among women (HR 0.92) even though the clear cell subtype, which has a more unfavorable prognosis, was more prevalent among women. 11 Other female clinicopathological features (lower pathological grade, earlier stage of detection, and higher prevalence of chromophobe subtype) linked to favorable prognosis may underlie these paradoxical sex differences in RCC histology and survival. 8, [11] [12] [13] Reports of sex differences in RCC histology and survival remain scarce in Asian settings. For example, in Japan, although the Japanese Urological Association has reported descriptive statistics of RCC histology and 5-year overall survival with multicenter data (but not population-based data), 18 sex differences in RCC histology and survival have not been previously assessed. One study in South Korea, with 1508 RCC patients, examined sex differences and reported lower prevalence of clear cell subtypes among women compared with men (female 72% vs male 84%) but a nonsignificant sex difference in survival, which contradicts the Western pattern. 19 However, this was a relatively small, single-center study, and it was not population based.
Accordingly, the goal of the present study was to examine sex differences in RCC histology and survival in Japan, using a large-scale population-based data set with over 5000 RCC patients. We sought to examine whether sex differences exist in RCC histology and whether there are overall survival differences by sex and by histological subtypes in Japan. Also, we sought to determine whether a sex difference in survival, if there is one, persists even after controlling for histological subtypes and other potential prognostic factors such as pathological grade, tumor stage, treatment, socioeconomic status (SES), and smoking habits.
| MATERIALS AND METHODS

| Data setting and study subjects
A large, population-based data set (2004-2016) of Kanagawa Cancer Registry (KCR), a survey of over nine million people in Kanagawa prefecture that covers approximately 7% of the Japanese population, was used for analysis. Details of the study database have been previously described elsewhere. 20, 21 Briefly, Kanagawa Prefecture, a metropolitan prefecture located next to Tokyo, is the second largest prefecture in Japan, and KCR is one of the largest local cancer registries in Japan. previous SEER studies. 6, 8, 22 The 5-year overall survival was defined by the right-censored, observation duration (person-years) from the date of initial diagnosis to the date of death/last follow-up (median follow-up time, 2.1 years).
Well
| Covariates
The age (1- and smoking habits (never/ever).
| Statistical analysis
The background characteristics between men and women were com- Table 2 ). The PR of the "others" subtype did not differ between men and women ( Table 2) .
In survival analyses, although the 5-year overall survival rate was 72% in this population, patients with the "others" subtype had a poor prognosis (30.3%, Table 1 ). However, no statistically significant differences were observed between men and women, even after stratifying by histological subtypes (Table 1 ). In the Cox regression analysis, although the chromophobe subtype predicted a better prognosis and the "others" subtype predicted a poor prognosis, only the "others" subtype predicted prognosis in the maximally adjusted model (HR 1.74; 95% CI 1.32-2.30, model 4, Table 3 ). However, we did not observe a statistically significant difference in the 5-year overall survival between men and women in model 1 through model 4 ( Table 3 ).
In sensitivity analyses, the observed patterns were almost identical to the main results ( Table 4 ). The multinomial odds ratios of women for the papillary, chromophobe, and "others" subtypes were, respectively, 0.64 (95% CI, 0.45-0.91), 3.25 (95% CI, 2.28-4.64), and 0.99 (95% CI, 0.75-1.30).
| DISCUSSION
As far as we are aware, this is the first analysis of sex differences in histology and survival in RCC patients in Japan. Compared with men, although women did not have a significantly different prevalence for clear cell and "others" subtypes, women had different prevalence for papillary and chromophobe subtypes (0.6 times lower prevalence for papillary subtype and 3.2 times higher prevalence for chromophobe subtype). Even after controlling for potential mediating factors, the sex difference for these histological subtypes persisted. However, the survival was similar between men and women, even after accounting 15, 17 which differs from the pattern seen in Western countries. 8, 13, 22 Although the prevalence of the clear cell subtype varies across populations and regions, studies in the United States and Europe consistently suggest a higher prevalence of the clear cell subtype among women, by approximately 2% to 7%. 8, [11] [12] [13] [14] 22 However, the prevalence of the clear cell subtype was not higher among women compared with men in our study population in Japan, which partly coincides with the result from South Korea. 19 Studies imply potential pathways of group-based differences in the risk for the clear cell subtype via obesity, smoking, hypertension, and end-stage renal disease in combination with genetic factors (APOL1 gene). 1, 12, 13, 15, 17, 24 Since obesity and smoking habits are far less common among Asian women compared with their counterparts in Western countries, 16, 25 the flat "gradient" of sex difference in the clear cell subtype seems plausible as an explanation for the discrepancy between the results obtained from Western and Asian countries. The sex difference in the other RCC histological subtypes may be consistent with the data from Western countries. In the Western settings, previous studies suggested that the papillary subtype was less prevalent (OR approximately 0.5 to 0.6) but that the chromophobe subtype was more prevalent (OR 2.3) among women compared with men. 12, 13 In our population-based study in Japan, we confirmed this pattern with similar magnitudes and directions (PRs for papillary and chromophobe subtypes were, respectively, 0.63 and 3.18). Some biological mechanisms, eg, androgen receptor expression, 26 may play a role. Yet, this sex difference is not wellcharacterized via biological pathways. In addition, the prevalence of the papillary (4.1%) and chromophobe (2.5%) subtypes in the total analyzed population, which parallels the statistics of the Japanese Urological Association, 18 is likely at the lower end of published estimates compared with data from previous studies, [6] [7] [8] 12, 13, 19 suggesting regional disparity in RCC histology.
Regarding sex disparities in RCC survival, women have been previously reported to have better prognosis compared with men, 11, 14, 19 which we did not observe in the present study. In the Western settings, better prognostic factors, including smaller tumor size, low pathological grade, and early stage, are likely more prevalent among women compared with men. 11, 14, 27 However, in this non-Western setting, we did not observe a sex difference in grade/stage. Similarly, a sex difference for grade/stage/tumor size was not found in South
Korea. 19 The similar distributions of better prognostic factors between men and women might partly underlie the observed absence of sex disparity in RCC survival in our study, as opposed to studies in the Western setting. 11 Several limitations in this study should be noted. First, although our data set was population-based, it only represents approximately 7% of the Japanese population in one geographic region, and our obtained pathology diagnoses were not based on a central pathology review. In addition, other relevant outcomes (eg, relative survival) 28 were not evaluated, and complete data were limited for histology and other prognostic variables (including stage) because of missing data, thereby limiting internal and external generalizability. However, our sensitivity analyses with multiple imputation and complete data yielded almost identical results. Second, although we assessed SES and smoking habits, we could not assess other potential predicting factors such as metabolic disorders (eg, obesity, hypertension, and diabetes), tumor size, or performance status, as seen in previous studies. 1, 6, 10, 11, 19 However, hypertension and diabetes did not affect prognosis in a previous study in South Korea. 19 Third, because of the limitation of the data, we were not able to classify histological subtypes further (such as type 1 and type 2 papillary RCC). 28 Since patients with type 2 papillary RCC tend to have poorer prognosis, 29 future studies focusing on sex differences in papillary RCC subtypes are needed.
Despite these limitations, the strengths of our study included the size, as this is one of the most extensive studies conducted for evaluating sex differences in RCC histology in the non-Western setting.
Our distribution of the clear cell subtype (88.2%) estimated with population-based data was similar to the SEER data, 6,7,11,21 suggesting our reduced bias compared with nonpopulation-based studies. 18, 19 In addition, while previous population-based studies did not include SES or smoking habits, 11 we were able to take account of these characteristics in our study.
Lastly, RCC patients with the "others" subtype tend to have a poorer prognosis compared with those with the clear cell subtype, 8, 30 and we confirmed this disparity in Japan. In contrast to good prognoses in clear cell, papillary, and chromophobe subtypes (even though survivals tend to differ slightly among the three subtypes), 7 prognosis of the "others" subtype remains poor, with aggressive pathological features (eg, approximately 50% of RCC patients having the "others" subtype tend to present with metastasis). 8 Hence, further studies exploring effects of standard and novel agents for this high-risk population are warranted. 29 In conclusion, sex differences in RCC histology (papillary and chromophobe subtypes but not clear cell and other subtypes) appear to exist in Japan, which differs from the pattern previously described 
